Dana-Farber Cancer Institute (DFCI) Wu Lab/Avicenne CLL RNA-Seq Study
|Study ID||Alternative Stable ID||Type|
Chronic Lymphocytic Leukemia (CLL) is a hematological malignancy characterized by accumulation of CD5+ B cells in peripheral lymphoid organs, bone marrow and blood. Recently, the advent of large-scale whole-exome sequencing of hundreds of CLL samples has led to gain a comprehensive understanding of the mutational landscape of this clonal B cell malignancy, but the functional effects of the putative driver mutations thus discovered are largely unknown. In this study, we analyze RNA-seq data from CLL patients to characterize dysregulated biological pathways regarding the presence of recurrent mutations.
|Archive||Link Archive Accession|
Who archives the data?
There are no publications available